Lazotep Sliver (Extended Art) Price

Updated 2026-05-06

Lazotep Sliver Extended Art is locked at floor, having shed -9.7% from its $12.03 peak over the past month while clawing back zero ground from current lows. The steady downward drift across both the 7-day (-2.5%) and 30-day (-9.7%) windows suggests this isn't a sharp correction but rather consistent liquidation pressure with no visible bid support. At $10.86, the foil rare from Commander Masters sits at its trough, meaning fresh bag holders are eating losses while earlier specs have likely rotated capital elsewhere. The absence of any rebound momentum signals weak demand for the extended art treatment despite the foil premium slot. Watch whether this card finds buyers below $10 or if the next 14 days bring fresh selling. If entry point hunters don't materialize soon, the floor could test further downside before any diamond hands narrative takes hold.